Genfleet Therapeutics (shanghai) Inc.
Clinical trials sponsored by Genfleet Therapeutics (shanghai) Inc., explained in plain language.
-
New hope for tough pancreatic cancer: targeted drug enters final testing
Disease control Not yet recruitingThis study is testing whether a new targeted drug called GFH375 works better than standard chemotherapy for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12D mutation) and has worsened after previous treatment. About 320 participants will be ran…
Phase: PHASE3 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug targets common Cancer-Causing mutation in major trial
Disease control Not yet recruitingThis study is testing a new drug called GFH276 in adults with advanced cancers that have a specific genetic change called a RAS mutation. The main goals are to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, lung, and colorectal cancer. It is an…
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC